Wayne Rackoff
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments 5
- Erythropoietin and Anemia Treatment 4
- Acute Myeloid Leukemia Research 3
- Oncology top 2%
- Neutropenia and Cancer Infections 5
- Reproductive Medicine top 2%
- Genetics top 5%
- Hemoglobinopathies and Related Disorders 8
- Blood disorders and treatments 3
-
- Radiopharmaceutical Chemistry and Applications 3
-
- Childhood Cancer Survivors' Quality of Life 3
Wayne Rackoff
35 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Hematology 823
- Oncology 1.0k
- Reproductive Medicine 286
- Pulmonary and Respiratory Medicine 945
- Genetics 275
Countries citing papers authored by Wayne Rackoff
This map shows the geographic impact of Wayne Rackoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wayne Rackoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wayne Rackoff more than expected).
Fields of papers citing papers by Wayne Rackoff
This network shows the impact of papers produced by Wayne Rackoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wayne Rackoff. The network helps show where Wayne Rackoff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wayne Rackoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 8 | |
| 2 | Apalutamide Treatment and Metastasis-free Survival in Prostate Cancerbreakdown → | 2018 | 868 |
| 3 | 2015 | 29 | |
| 4 | 2007 | 52 | |
| 5 | 2007 | 59 | |
| 6 | 2004 | 337 | |
| 7 | 2004 | 15 | |
| 8 | 2003 | 38 | |
| 9 | 1999 | 28 | |
| 10 | 1998 | 23 | |
| 11 | 1998 | 1 | |
| 12 | 1996 | 178 | |
| 13 | 1995 | 80 | |
| 14 | 1994 | 8 | |
| 15 | A case-control retrospective study of the efficacy of granulocyte-colony-stimulating factor in children with neuroblastoma. | 1994 | 9 |
| 16 | Treatment of refractory Evans syndrome with alternate-day cyclosporine and prednisone. | 1994 | 18 |
| 17 | 1992 | 72 | |
| 18 | 1992 | 1 | |
| 19 | 1991 | 5 | |
| 20 | 1984 | 28 |
About Wayne Rackoff
Wayne Rackoff is a scholar working on Hematology, Genetics, Emergency Medical Services, Oncology and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 2.9k indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (8 papers), Chronic Myeloid Leukemia Treatments (5 papers), Neutropenia and Cancer Infections (5 papers), Erythropoietin and Anemia Treatment (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Childhood Cancer Survivors' Quality of Life (3 papers), Blood disorders and treatments (3 papers) and Acute Myeloid Leukemia Research (3 papers). The work is most often cited by research in Hematology (823 citations), Oncology (1.0k citations), Reproductive Medicine (286 citations), Pulmonary and Respiratory Medicine (945 citations) and Genetics (275 citations). Wayne Rackoff has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Steven Sun, Margaret Tonda, Alan N. Gordon, Hiroji Uemura, Fred Saad, Angela Lopez‐Gitlitz, David Olmos, Boris Hadaschik, Margaret K. Yu and Ji Youl Lee. Their work appears in journals such as Journal of Clinical Oncology, Blood, The Journal of Pediatrics, Journal of Pediatric Hematology/Oncology and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.